Expression of human CD44v6 in non-small-cell lung cancer

European Surgical Research

Volumn 30, Issue 6, 1998, Pages 403-408

  Carbognani, P ^a   Spaggiari, L ^a   Romani, A ^a   Solli, P ^a   Corradi, A ^a   Cantoni, Anna Maria ^a   Petronini, P G ^a   Borghetti, A F ^a   Rusca, M ^a   Bobbio, P ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Cancer; CD44v6; Lung; Marker; Non small cell lung cancer

Indexed keywords

CD44V ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

EID: 7844252588     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008605     Document Type: Article

References (29)

1. Haynes BF, Telen LJ, Hale LP, Dennings SM: CD44 a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989;10:423-428.
2. Jalkanen ST, Bargatze RF, Herron LR, Butcher EC: A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 1990;16:1195-1202.
3. Dennings SM, Le PT, Singer HK, Haynes BF: Antibodies against the CD44 p80, lymphocyte homing receptor molecule, augment human peripheal blood T cell activation. J Immunol 1990;144:7-15.
4. Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Berbard A: CD44 contributes to T cell activation, J Immunol 1989;143:798-801.
5. Miyake K, Medina KL, Hayashi SI, Hamahoka S, Ono T, Kinkade PW: Monoclonal antibodies to Pgp-1/CD44 block lympho-hematopoiesis in long term bone marrow culture. J Exp Med 1990;172:69-75.
6. Koopman G, van Kooyk Y, de Graaff M, Meijer CJLM, Figdor JC, Pals ST: Triggering of the CD44 antigen on T lymphocyte promotes T adhesion through the LFA-1 pathway. J Immunol 1990;145:3589-3593.
7. Hoffmann M, Rudy W, Zöller M, Toig C, Ponta H, Herrlich P, et al: CD44 splice variants confer metastatic behaviour in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res 1991;51:5292-5297.
8. Gunthert U, Hoffmann M, Rudy W, Reber S, Zöller M, Haussmann I, et al: A new variant of glycoprotein CD44 confer metastatic potential to rat carcinoma cells. Cell 1991;65: 13-24.
9. Jalkanen ST, Jalkanen M, Bargatze R, Tammi M, Butcher EC: Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venule in man. J Immunol 1988;141:1615-1623.
10. Carter WG, Wayner EA: Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 1988;263:4193-4201.
11. Haggerty JG, Bretton RH, Milstone LM: Identification and characterization of a cell surface proteoglycan on keratinocytes. J Invest Dermatol 1992;99:374-380.
12. Brown TA, Bouchard T, St John T, Wayner E, Carter WG: Human keratinocytes express a new CD44 core protein (CD44E) as heparan-sulfate intrinsic membrane glycoprotein with additional exon. J Cell Biol 1991;113:207-221.
13. Lesley J, Hyman R, Kinkade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54:271-335.
14. Goodfellow PN, Banting G, Wiles MV, Tunnacliffe A, Parker M, Solomon E, et al: The gene, MIC4, which controls expression of antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11. Eur J Immunol 1982;12:659-663.
15. Screaton GR, Bell MV, Jackson DG, Cornelis F, Gerth U, Bell JL: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Nail Acad Sci USA 1992;89:12160-12164.
16. Ponta H, Sleeman J, Herrlich P: Tumor metastasis formation: Cell-surface proteins confer metastasis-promoting or -suppressing properties. Biochim Biophys Acta 1994; 1198: 1-10.
17. Heider KH, Huffman M, Hors E, van den Berg F, Ponta H, Herrlich P, et al: A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993;120:227-233.
18. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, et al: Expression of CD44 in human lung tumors. Cancer Res 1994:54:1381-1387.
19. St John T, Meyer R, Iderza R, Gallatin WM: Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 1990;60:45-50.
20. Miyake K, Kinkade PW: A new cell adhesion mechanism involving hyaluronate and CD44. Curr Top Microbiol Immunol 1990;166:87-93.
21. Jalkanen S, Jalkanen M: Lymphocyte CD44 binds to the terminal heparin binding domain of fibronectin. J Cell Biol 1992;116:817-825.
22. Ariza A, Mate LJ, Isamat M, Lopez D, Von Uexkull-Guldeband C, Rosell R, et al: Standard and variant CD44 isoforms are commonly expressed in lung cancer of the nonsmall cell type but not of the small cell type. J Pathol 1995;177:363-368.
23. Fasano M, Sabatini MT, Wieczorek R, Sidhu G, Goswami S, Jagirdar J: CD44 and its v6 spliced variant in lung tumors. A role in histogenesis? Cancer 1997;80-34-41.
24. Heider KH, Dammlich J, Skroch AP, Müller-Hermelink HK: Differential expression of CD44 variants in intestinal- and diffuse type human gastric carcinoma and normal gastric mucosa. Cancer Res 1993; 53:4197-4203.
25. Harn HJ, Ho Li, Chang Ly, WuCW: Differential expression of the human metastatic adhesion molecule in normal and carcinomatous stomach mucosa of Chinese subject. Cancer 1995;75:1065-1071.
26. Stamenkovic I, Amiot M, Pesandro JM, Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989;56:1057-1062.
27. Goldstein LA, Zou DFH, Picker LJ, Minty CN, Bargatze RF, Ding JF, et al: A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 1989;56:1063-1072.
28. Aruffo A, Stamenkovic M, Melnick M. Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-1313.
29. Bertrand P, Girard N: Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: Comparison between invasive and nonivasive areas, Int J Cancer 1992; 52:1-6.